Abm

Developer of small molecules therapeutics to treat cancer

placePudong, Shanghai, China calendar_todayFounded 2015 language abmtx.com

Registered entities

Investor mix

17 investors on record; lead investors include Jiangsu Honghui Equity Investment Management, Photon Fund, China Growth Capital, Kaitai Capital Management.

Investor typeCountShare
Venture capital1165%
Private equity318%
Other / undisclosed318%
Coming soon